CV Sciences, Inc. · OTC:CVSI

CV Sciences — Investor Presentation (October 2023)

19 slides from CV Sciences's investor presentation, October 2023

  1. Slide 1: CV Sciences

    oi Sci ms +PlusCBD daily ZL ay balance CBD THC PULL Spectrum HEMP EXTRACT 25 os IMC Seiuscep +PwusceED

  2. Slide 2: Safe Harbor & Disclaimer

    Safe Harbor & Disclaimor This presentation may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. T

  3. Slide 3: Company Overview

    Company Overview • Highly trusted brand in market for 10 years, launched flagship brand +PlusCBD in 2014. • One of the largest retail footprints in the industry with 4,000+ points of distribution in the U.S. • Strong ecommerce operation supporting Omni-channel strategy. • #1 Selling Brand in Natural

  4. Slide 4: Brand Overview

    Brand Overview Distribution Description Images 4,000+ B2B locations, E- In Market since 2014, includes +PlusCBD commerce Full Spectrum & THC-free Formats include gummies, softgels, liquids and topicals 4,000+ B2B locations, E- In Market since 2021, products Wellness line commerce include health clai

  5. Slide 5: Sales Model – Omnichannel Strategy B2B & B2C

    Sales Model – Omnichannel Strategy B2B & B2C 5

  6. Slide 6: Distribution

    Distribution • All brands are distributed in B2B and B2C. • B2B distribution includes Natural Product Retail (2,000+ locations), FDM (1,000+ locations & Specialty (1,000+ locations). • Sales model includes external broker network for NPR channel, internal sales staff supporting all channels. • Stron

  7. Slide 7: B2B - Sales Model

    B2B - Sales Model • Broker relationships covering all U.S. markets • Relationships with “buyers” and “consumers” • Keeps us very close to the customer 7

  8. Slide 8: B2B - Sales Model

    B2B - Sales Model • Strongest B2B retail penetration for CBD industry 8

  9. Slide 9: SPINS Data

    SPINS Data (1) (1) SPINS is the leading provider of syndicated data and insights for the natural, organic and specialty products industry. 9

  10. Slide 10: Market Leader in Natural Products Retail (NPR) Channel

    Market Leader in Natural Products Retail (NPR) Channel Percentage of Total Market Da ta th ro u g h :2 0 2 3 -Ju l-1 6 Fu n ctio n a l In g red ien ts: Ca n n a b id io l (CBD) a n d Hemp 45% P ro d u cts b y Bra n d Dols, % Chg, Yago Units 40% 52wks 24wks 12wks 4wks 52wks 24wks 12wks 4wks 35% Total

  11. Slide 11: NPR Channel – Brands sold per month

    • • present continues Brand contraction post 2018 Farm Bill to Brands sold per month – 130 150 160 170 180 190 200 210 140 2/3/19 145 3/3/19 146 4/3/19 154 5/3/19 159 6/3/19 167 7/3/19 174 178 8/3/19 185 9/3/19 186 10/3/19 185 11/3/19 192 12/3/19 192 1/3/20 198 2/3/20 194 3/3/20 200 4/3/20 195 5/3/2

  12. Slide 12: Ecommerce Overview

    Ecommerce Overview What this shows: • 41% of our revenue is derived from ecommerce. • Very loyal customer base. • Key metrics: a) 70,000+ monthly visits b) Conversion rate – ≈ 7.0% c) AOV - ≈ $80.00 Opportunity: • Ecommerce infrastructure is built and ready for significant scale 12

  13. Slide 13: Financial Information

    +PlusCBD by CV SCIENCES Financial Information 13

  14. Slide 14: Adjusted EBITDA

    Adjusted EBITDA (in $M) Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Product sales, net $ 4.8 $ 5.1 $ 5.1 $ 5.0 $ 4.4 $ 4.1 $ 3.8 $ 3.9 $ 4.1 $ 4.0 Gross profit $ 2.4 $ 2.3 $ 2.4 $ 1.6 $ 1.2 $ 1.3 $ 1.6 $ 1.6 $ 1.8 $ 1.7 48.7% 44.7% 46.2% 32.4% 26.0% 30.7% 41.6% 40.4% 43.0% 43.3% R&D

  15. Slide 15: Regulatory Inflection Points

    Regulatory Inflection Points 15

  16. Slide 16: Regulatory Environment – Key Legislation

    Regulatory Environment – Key Legislation • Safe Banking: Senate Banking Committee approved on September 27, 2023. Allows banks to work with cannabis businesses without penalty. • Rescheduling: DEA likely to reschedule cannabis to Schedule III • Garland Memo: Likely to follow “Cole Memo” with a Feder

  17. Slide 17: Growth Opportunities

    +PlusCBD by CV SCIENCES Growth Opportunities 17

  18. Slide 18: Growth Opportunities

    Growth Opportunities • Market share increase from brand contraction. • Brand consolidation through M&A. • Product innovation supported by evidence-based science. • Leverage key assets: retail distribution, strong brand awareness, strong infrastructure and people. • Complimentary CPG products in “hea

  19. Slide 19: Thank You

    +PlusCBD by CV SCIENCES Thank You 19

CV Sciences — Investor Presentation (October 2023) on 6ix